PVRL2 抗体
(Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2))
This gene encodes a single-pass type I membrane glycoprotein with two Ig-like C2-type domains and an Ig-like V-type domain. This protein is one of the plasma membrane components of adherens junctions. It also serves as an entry for certain mutant strains of herpes simplex virus and pseudorabies virus, and it is involved in cell to cell spreading of these viruses. Variations in this gene have been associated with differences in the severity of multiple sclerosis. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PVRL2 抗体 (AA 32-350) | 人 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (Extracellular Domain) | 人, 小鼠 | 大鼠 Monoclonal |
|
|
|
| PVRL2 抗体 (AA 32-360) | 人 | 小鼠 Monoclonal |
|
|
|
| PVRL2 抗体 (AA 32-360) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (AA 32-360) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (AA 32-360) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 | 人 | 兔 Polyclonal |
|
|
|
| Recombinant PVRL2 抗体 (Biotin) | 人 | Human, 兔 Chimeric |
|
|
|
| PVRL2 抗体 (Internal Region) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (Extracellular Domain) (FITC) | 人, 小鼠 | 大鼠 Monoclonal |
|
|
|
| PVRL2 抗体 (FITC) | 人 | HEK-293F Cells Polyclonal |
|
|
|
| PVRL2 抗体 (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 | 人, 小鼠, 大鼠 | 兔 Monoclonal |
|
|
|
| PVRL2 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PVRL2 抗体 (Middle Region) | 人, 小鼠, Pig | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (AA 32-348) (APC) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (AA 32-348) (HRP) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (AA 32-348) (Biotin) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (AA 32-348) (FITC) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| PVRL2 抗体 (AA 32-348) (Fluoro550) | 人, 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 32-350
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 502-57
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- Extracellular Domain
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- TS106
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 32-360
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 32-360
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 32-360
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 32-360
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- Human, 兔
- 克隆形成能力
- Chimeric
- 克隆
- DMC224
- 标记
- Biotin
- Fragment
- Fc fragment
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Internal Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 13A61
- 标记
- FITC
- 抗体亚型
- IgG2a
- 抗原表位
- Extracellular Domain
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- HEK-293F Cells
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, Pig
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 32-348
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 32-348
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 32-348
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 32-348
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 32-348
Latest Publications for our PVRL2 抗体
: "CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 50, pp. E11731-E11740, (2019) (PubMed).
: "Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity." in: Journal of neuroinflammation, Vol. 16, Issue 1, pp. 49, (2019) (PubMed).
: "The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing." in: European journal of immunology, Vol. 49, Issue 6, pp. 873-883, (2019) (PubMed).
: "Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function." in: BMC immunology, Vol. 20, Issue 1, pp. 8, (2019) (PubMed).
: "Nectin-2 in ovarian cancer: How is it expressed and what might be its functional role?" in: Cancer science, Vol. 110, Issue 6, pp. 1872-1882, (2019) (PubMed).
: "Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model." in: Scientific reports, Vol. 9, Issue 1, pp. 10840, (2019) (PubMed).
: "Cultivation and characterization of pterygium as an ex vivo study model for disease and therapy." in: Contact lens & anterior eye : the journal of the British Contact Lens Association, Vol. 40, Issue 5, pp. 283-292, (2018) (PubMed).
: "Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity." in: Nature immunology, Vol. 19, Issue 7, pp. 723-732, (2018) (PubMed).
: "Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 201, Issue 7, pp. 2028-2041, (2018) (PubMed).
: "Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells." in: Scientific reports, Vol. 7, Issue 1, pp. 10445, (2017) (PubMed).
: "Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity." in: Journal of neuroinflammation, Vol. 16, Issue 1, pp. 49, (2019) (PubMed).
: "The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing." in: European journal of immunology, Vol. 49, Issue 6, pp. 873-883, (2019) (PubMed).
: "Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function." in: BMC immunology, Vol. 20, Issue 1, pp. 8, (2019) (PubMed).
: "Nectin-2 in ovarian cancer: How is it expressed and what might be its functional role?" in: Cancer science, Vol. 110, Issue 6, pp. 1872-1882, (2019) (PubMed).
: "Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model." in: Scientific reports, Vol. 9, Issue 1, pp. 10840, (2019) (PubMed).
: "Cultivation and characterization of pterygium as an ex vivo study model for disease and therapy." in: Contact lens & anterior eye : the journal of the British Contact Lens Association, Vol. 40, Issue 5, pp. 283-292, (2018) (PubMed).
: "Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity." in: Nature immunology, Vol. 19, Issue 7, pp. 723-732, (2018) (PubMed).
: "Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 201, Issue 7, pp. 2028-2041, (2018) (PubMed).
: "Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells." in: Scientific reports, Vol. 7, Issue 1, pp. 10445, (2017) (PubMed).
Aliases for PVRL2 抗体
nectin cell adhesion molecule 2 (Nectin2) 抗体nectin cell adhesion molecule 2 (NECTIN2) 抗体
AI325026 抗体
AI987993 抗体
Cd112 抗体
CD112 抗体
HVEB 抗体
MPH 抗体
nectin-2 抗体
prr2 抗体
PRR2 抗体
Pvr 抗体
PVRR2 抗体
Pvs 抗体
您还需要查找其他产品吗？
- PVRL1 抗体
- PVRIG 抗体
- PUSL1 抗体
- PUS3 抗体
- PUS10 抗体
- PUS1 抗体
- Purinergic Receptor P2Y, G-Protein Coupled, 13 抗体
- Purinergic Receptor P2x, Ligand-Gated Ion Channel, 3 抗体
- Purine-Rich Element Binding Protein B 抗体
- Purine Nucleoside Phosphorylase 抗体
- PURA 抗体
- PUMA 抗体
- PUM2 抗体
- PUM1 抗体
- PTX4 抗体
- PTX3 抗体
- PTTG1IP 抗体
- PTTG1 抗体
- PTS 抗体
- PTRHD1 抗体
You are here:
